{"id":"W2998268837","doi":"10.1212/wnl.0000000000008860","title":"Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Trametinib; Dabrafenib; Myasthenia gravis; Medicine; Melanoma; MEK inhibitor; Neuromuscular transmission; Immunotherapy; Cancer research; Oncology; Internal medicine; Immunology; Cancer; MAPK/ERK pathway; Metastatic melanoma; Kinase; Biology; Vemurafenib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004561226,0.00108824,0.001138217,0.001060622,0.001738528,0.0009115213,0.0009433856,0.003267763,0.002019443],"category_scores_gemma":[0.003020017,0.0004167489,0.00118802,0.0008099068,0.001079487,0.001094378,0.0009326436,0.003298385,0.0008215542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002906571,"about_ca_system_score_gemma":0.001419617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00690791,"about_ca_topic_score_gemma":0.01207433,"domain_scores_codex":[0.9993943,0.00007261261,0.00004333743,0.00009179557,0.0001112396,0.0002866103],"domain_scores_gemma":[0.9981731,0.0004626308,0.0004509604,0.0001260054,0.0001434958,0.0006438051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0001444467,0.00007986345,0.006950943,0.00003174925,0.00002323483,0.9887135,0.0001467403,0.0001118979,0.0007062132,0.0001438975,0.000256813,0.002690685],"study_design_scores_gemma":[0.00007098284,0.000525958,0.02727109,0.00004323183,0.00004995662,0.9691893,0.0001215081,0.0005880131,0.0006421262,0.00029316,0.001185661,0.00001900829],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9526315,0.006368482,0.001749954,0.00410345,0.0004577495,0.0002881461,0.0001890855,0.0002210916,0.03399048],"genre_scores_gemma":[0.9949114,0.0008825405,0.0002356061,0.001395095,0.0003317668,0.00002129684,0.00007322273,0.0000126228,0.002136538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00690791,"threshold_uncertainty_score":0.02108878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01488183973930225,"score_gpt":0.2724180623658692,"score_spread":0.257536222626567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}